Status:

ACTIVE_NOT_RECRUITING

DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study

Lead Sponsor:

Mayo Clinic

Conditions:

Genetic Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This clinical trial collects information on how sequencing a patient's deoxyribonucleic acid (DNA) (i.e., the genetic material) could impact their health care. This study also develops and improves wa...

Detailed Description

PRIMARY OBJECTIVES: I. To detect and compare the actionable genetic findings derived from whole exome sequencing (WES) testing and examine their frequency and association with family history using a ...

Eligibility Criteria

Inclusion

  • Age \>= 18 years
  • Registered Mayo Clinic patient
  • Able to provide informed written consent
  • E-mail and web access (for electronic consent, video education, registering with Helix and receiving results)
  • Ability to collect and ship saliva sample within the United States
  • Of note: Women, who are pregnant, or planning to become pregnant, can take part in this study. However, this study does not replace prenatal genetic testing. If participants have these concerns, they will be encouraged to contact their obstetrics (OB) provider or a genetic counselor to discuss further

Exclusion

  • Other co-morbidity which would in physician's opinion interferes with patient's ability to participate in the study (eg: reduced ability to comprehend eg: dementia, intellectual disability, fluency in consent language)
  • Allogeneic bone marrow transplant (e.g. samples from autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant)
  • Active hematological cancer or history of a hematological cancer
  • Resident of the state of New York
  • The Helix lab does not currently have New York state licensure
  • Residents without a shipping address in the United States
  • The Helix lab is unable to ship and receive samples internationally

Key Trial Info

Start Date :

January 22 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

110000 Patients enrolled

Trial Details

Trial ID

NCT05212428

Start Date

January 22 2020

End Date

December 31 2026

Last Update

December 17 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Mayo Clinic in Arizona

Scottsdale, Arizona, United States, 85259

2

Mayo Clinic in Florida

Jacksonville, Florida, United States, 32224-9980

3

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905